As of 2025-05-13, the Fair Value of Castle Biosciences Inc (CSTL) is -0.88 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.04 USD, the upside of Castle Biosciences Inc is -105.16%.
With the market price of 17.04 USD and our fair value calculation, Castle Biosciences Inc (CSTL) is not a good investment. Investing in CSTL stocks now will result in a potential loss of 105.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -10.30 | -31.30 | -67.10 | -57.47 | 18.25 | -29.58 |
| YoY growth | -294.34% | -203.88% | -114.38% | 14.36% | 131.75% | -93.30% |
| Market Cap (mil) | 491.43 |
| P/E | |
| Forward P/E | 17.03x |
| EPS | -0.18 |
| Avg earnings growth rate | -93.30% |
| TTM earnings | -5.07 |